Статус неизвестен
Фаза III
Казахстан
Elbasvir/ Grazoprevir 50/100 mg fixed dose combination · Institute Of Cardiology & Internal Diseases, Kazakhstan
Open-Label Multi-Center Single Arm Clinical Trial to Study the Efficacy and Safety of the Elbasvir/ Grazoprevir 50/100 mg Fixed Dose Combination Once Daily in Patients With Chronic HCV GT1b Infection Associated With Metabolic Syndrome